Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
Recruiting
18 years - 70 years
All
Phase
3
5 participants needed
1 Location
Brief description of study
To investigate the safety and efficacy of Tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Diabetic Gastroparesis
-
Age: 18 years - 70 years
-
Gender: All
Male or Female, Age 18-70, Diagnosed with gastroparesis
Updated on
04 Aug 2024.
Study ID: 834091